Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
ORLANDO — For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control — for
WASHINGTON — The House Energy & Commerce health subcommittee kicked off its first hearing in four years on whether to reform the way Medicare pays
What You Should Know: – Boehringer Ingelheim and IBM announced a collaboration to leverage IBM’s foundation model technologies for the discovery of novel candidate antibodies